[N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate

C29H31FN6O3 — CID 174020993

IUPAC[N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate
SMILES[H]/N=C(/OC(N)=N[C@H]1N=C(c2ccccc2)C2=CC=CCC2NC1=O)c1ccc(F)cc1N1C[C@@H](C)O[C@@H](C)C1
InChIInChI=1S/C29H31FN6O3/c1-17-15-36(16-18(2)38-17)24-14-20(30)12-13-22(24)26(31)39-29(32)35-27-28(37)33-23-11-7-6-10-21(23)25(34-27)19-8-4-3-5-9-19/h3-10,12-14,17-18,23,27,31H,11,15-16H2,1-2H3,(H2,32,35)(H,33,37)/b31-26+/t17-,18+,23?,27-/m1/s1
InChIKeyMQKSKYNKRHKSHU-FXDMDENASA-N
MW530.60 g/mol
LogP3.30
Rot. Bonds4

About [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate

[N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate (PubChem CID 174020993) has the molecular formula C29H31FN6O3 and a molecular weight of 530.60 g/mol. Its IUPAC name is [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate.

Molecular Properties

Compound Name[N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate
PubChem CID174020993
Molecular FormulaC29H31FN6O3
Molecular Weight530.60 g/mol
Exact Mass530.24
IUPAC Name[N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate
SMILES[H]/N=C(/OC(N)=N[C@H]1N=C(c2ccccc2)C2=CC=CCC2NC1=O)c1ccc(F)cc1N1C[C@@H](C)O[C@@H](C)C1
InChIInChI=1S/C29H31FN6O3/c1-17-15-36(16-18(2)38-17)24-14-20(30)12-13-22(24)26(31)39-29(32)35-27-28(37)33-23-11-7-6-10-21(23)25(34-27)19-8-4-3-5-9-19/h3-10,12-14,17-18,23,27,31H,11,15-16H2,1-2H3,(H2,32,35)(H,33,37)/b31-26+/t17-,18+,23?,27-/m1/s1
InChIKeyMQKSKYNKRHKSHU-FXDMDENASA-N
XLogP3.30
TPSA125.39 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds4
Heavy Atoms39
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500530.60
LogP ≤ 53.30
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate?
The IUPAC name of [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate (CID 174020993) is [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate.
What is the SMILES notation for [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate?
The canonical SMILES for [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate is [H]/N=C(/OC(N)=N[C@H]1N=C(c2ccccc2)C2=CC=CCC2NC1=O)c1ccc(F)cc1N1C[C@@H](C)O[C@@H](C)C1.
What is the InChIKey of [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate?
The InChIKey is MQKSKYNKRHKSHU-FXDMDENASA-N. The full InChI is InChI=1S/C29H31FN6O3/c1-17-15-36(16-18(2)38-17)24-14-20(30)12-13-22(24)26(31)39-29(32)35-27-28(37)33-23-11-7-6-10-21(23)25(34-27)19-8-4-3-5-9-19/h3-10,12-14,17-18,23,27,31H,11,15-16H2,1-2H3,(H2,32,35)(H,33,37)/b31-26+/t17-,18+,23?,27-/m1/s1.
What are the key properties of [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate?
[N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate has a molecular weight of 530.60 g/mol, XLogP of 3.30, 4 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [N'-[(3R)-2-oxo-5-phenyl-1,3,9,9a-tetrahydro-1,4-benzodiazepin-3-yl]carbamimidoyl] 2-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-fluorobenzenecarboximidate is sourced from PubChem (CID 174020993), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).